Peter Ripphausen

State-of-the-art in ligand-based virtual screening.

J. Bajorath, Peter Ripphausen, Britta Nisius, 2011, Drug discovery today.

Quo vadis, virtual screening? A comprehensive survey of prospective applications.

J. Bajorath, Lisa Peltason, Peter Ripphausen, 2010, Journal of medicinal chemistry.

REPROVIS-DB: A Benchmark System for Ligand-Based Virtual Screening Derived from Reproducible Prospective Applications

Anne Mai Wassermann, Jürgen Bajorath, Peter Ripphausen, 2011, J. Chem. Inf. Model..

Analysis of structure-based virtual screening studies and characterization of identified active compounds.

Jürgen Bajorath, Dagmar Stumpfe, Peter Ripphausen, 2012, Future medicinal chemistry.

Development of potent and selective inhibitors of ecto-5'-nucleotidase based on an anthraquinone scaffold.

J. Bajorath, C. Müller, Peter Ripphausen, 2010, Journal of medicinal chemistry.

Virtual screening identifies novel sulfonamide inhibitors of ecto-5'-nucleotidase.

J. Bajorath, C. Müller, Peter Ripphausen, 2012, Journal of medicinal chemistry.

Virtual compound screening in drug discovery.

Jürgen Bajorath, Dagmar Stumpfe, Peter Ripphausen, 2012, Future medicinal chemistry.

Analysis of structure-based virtual screening studies and characterization of identified active compounds.

J. Bajorath, Dagmar Stumpfe, Peter Ripphausen, 2012, Future medicinal chemistry.